These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 23889950)
1. Quality of post-treatment surveillance of early stage breast cancer in Texas. Parmar AD; Sheffield KM; Vargas GM; Han Y; Chao C; Riall TS Surgery; 2013 Aug; 154(2):214-25. PubMed ID: 23889950 [TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367 [TBL] [Abstract][Full Text] [Related]
3. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer. Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451 [TBL] [Abstract][Full Text] [Related]
4. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer. Vargas GM; Sheffield KM; Parmar AD; Han Y; Brown KM; Riall TS Surgery; 2013 Aug; 154(2):244-55. PubMed ID: 23889952 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients. Jung NY; Yoo IR; Kang BJ; Kim SH; Chae BJ; Seo YY Breast Cancer; 2016 Jan; 23(1):141-148. PubMed ID: 24872087 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer. Groheux D; Hindié E; Delord M; Giacchetti S; Hamy AS; de Bazelaire C; de Roquancourt A; Vercellino L; Toubert ME; Merlet P; Espié M J Natl Cancer Inst; 2012 Dec; 104(24):1879-87. PubMed ID: 23243198 [TBL] [Abstract][Full Text] [Related]
7. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population. Crivello ML; Ruth K; Sigurdson ER; Egleston BL; Evers K; Wong YN; Boraas M; Bleicher RJ Ann Surg Oncol; 2013 Jan; 20(1):102-10. PubMed ID: 22878617 [TBL] [Abstract][Full Text] [Related]
8. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC; Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer. Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152 [TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening. Peng NJ; Chou CP; Pan HB; Chang TH; Hu C; Chiu YL; Fu TY; Chang HT J Med Imaging Radiat Oncol; 2015 Aug; 59(4):445-452. PubMed ID: 25872026 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of follow-up imaging on mortality in Korean breast cancer patients: A national cohort study. Jung SY; Kim YA; Lee DE; Joo J; Back JH; Kong SY; Lee ES Cancer Med; 2021 Sep; 10(18):6480-6491. PubMed ID: 34472221 [TBL] [Abstract][Full Text] [Related]
12. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast. Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000 [TBL] [Abstract][Full Text] [Related]
13. Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy. Meyer C; Millán P; González V; Spera G; Machado A; Mackey JR; Fresco R Clin Breast Cancer; 2019 Jun; 19(3):e468-e474. PubMed ID: 30850181 [TBL] [Abstract][Full Text] [Related]
14. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy. Vapiwala N; Hwang WT; Kushner CJ; Schnall MD; Freedman GM; Solin LJ Cancer; 2017 Apr; 123(8):1324-1332. PubMed ID: 27984658 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Yang WT; Le-Petross HT; Macapinlac H; Carkaci S; Gonzalez-Angulo AM; Dawood S; Resetkova E; Hortobagyi GN; Cristofanilli M Breast Cancer Res Treat; 2008 Jun; 109(3):417-26. PubMed ID: 17653852 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma. Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295 [TBL] [Abstract][Full Text] [Related]
17. Workup and staging of locally advanced breast cancer. Whitman GJ; Strom EA Semin Radiat Oncol; 2009 Oct; 19(4):211-21. PubMed ID: 19732685 [TBL] [Abstract][Full Text] [Related]
18. Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features. Lee YJ; Choi BB; Suh KS Acta Radiol; 2015 Jun; 56(6):644-51. PubMed ID: 24938660 [TBL] [Abstract][Full Text] [Related]
19. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer staging in a single session: whole-body PET/CT mammography. Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]